vs
Side-by-side financial comparison of Allot Ltd. (ALLT) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.
Allot Ltd. is the larger business by last-quarter revenue ($24.1M vs $13.8M, roughly 1.7× Gossamer Bio, Inc.). Allot Ltd. runs the higher net margin — -7.0% vs -342.3%, a 335.3% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 8.5%).
Allot Ltd., formerly Allot Communications, is an Israeli high-tech company that develops telecommunications software. The company is headquartered in Hod Hasharon, Israel.
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
ALLT vs GOSS — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.1M | $13.8M |
| Net Profit | $-1.7M | $-47.2M |
| Gross Margin | 72.1% | — |
| Operating Margin | -1.7% | -333.6% |
| Net Margin | -7.0% | -342.3% |
| Revenue YoY | 8.5% | 47.1% |
| Net Profit YoY | 49.6% | -43.0% |
| EPS (diluted) | $-0.04 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $13.8M | ||
| Q3 25 | — | $13.3M | ||
| Q2 25 | $24.1M | — | ||
| Q1 25 | $23.1M | — | ||
| Q2 24 | $22.2M | $95.8M | ||
| Q1 24 | — | $0 | ||
| Q3 23 | — | $0 | ||
| Q2 23 | $25.0M | $0 |
| Q4 25 | — | $-47.2M | ||
| Q3 25 | — | $-48.2M | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-332.0K | — | ||
| Q2 24 | $-3.4M | $49.2M | ||
| Q1 24 | — | $-41.9M | ||
| Q3 23 | — | $-40.0M | ||
| Q2 23 | $-20.7M | $-42.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 69.3% | — | ||
| Q2 24 | 68.5% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 69.2% | — |
| Q4 25 | — | -333.6% | ||
| Q3 25 | — | -369.4% | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -3.1% | — | ||
| Q2 24 | -15.2% | 54.3% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | -85.8% | — |
| Q4 25 | — | -342.3% | ||
| Q3 25 | — | -362.7% | ||
| Q2 25 | -7.0% | — | ||
| Q1 25 | -1.4% | — | ||
| Q2 24 | -15.1% | 51.4% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | -82.8% | — |
| Q4 25 | — | $-0.21 | ||
| Q3 25 | — | $-0.21 | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q2 24 | $-0.09 | $0.22 | ||
| Q1 24 | — | $-0.19 | ||
| Q3 23 | — | $-0.21 | ||
| Q2 23 | $-0.55 | $-0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.1M | $136.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $99.7M | $-122.8M |
| Total Assets | $154.1M | $172.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $136.9M | ||
| Q3 25 | — | $180.2M | ||
| Q2 25 | $60.1M | — | ||
| Q1 25 | $10.1M | — | ||
| Q2 24 | $15.9M | $354.5M | ||
| Q1 24 | — | $244.4M | ||
| Q3 23 | — | $328.9M | ||
| Q2 23 | $15.5M | $162.1M |
| Q4 25 | — | $-122.8M | ||
| Q3 25 | — | $-82.3M | ||
| Q2 25 | $99.7M | — | ||
| Q1 25 | $50.0M | — | ||
| Q2 24 | $46.7M | $81.5M | ||
| Q1 24 | — | $26.7M | ||
| Q3 23 | — | $104.6M | ||
| Q2 23 | $76.1M | $-62.8M |
| Q4 25 | — | $172.2M | ||
| Q3 25 | — | $208.8M | ||
| Q2 25 | $154.1M | — | ||
| Q1 25 | $140.3M | — | ||
| Q2 24 | $132.5M | $373.4M | ||
| Q1 24 | — | $259.4M | ||
| Q3 23 | — | $347.9M | ||
| Q2 23 | $177.8M | $181.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-48.3M |
| Free Cash FlowOCF − Capex | $4.0M | — |
| FCF MarginFCF / Revenue | 16.5% | — |
| Capex IntensityCapex / Revenue | 1.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-6.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-48.3M | ||
| Q3 25 | — | $-36.2M | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $1.7M | — | ||
| Q2 24 | $1.2M | $116.3M | ||
| Q1 24 | — | $-52.3M | ||
| Q3 23 | — | $-34.5M | ||
| Q2 23 | $-11.3M | $-38.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $4.0M | — | ||
| Q1 25 | $1.4M | — | ||
| Q2 24 | $217.0K | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | $-11.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 6.1% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | -46.4% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.2% | — | ||
| Q2 24 | 4.3% | 0.0% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 1.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 2.36× | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
